Literature DB >> 2173911

A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus.

Y Ohshita1, K Hiramatsu, T Yokota.   

Abstract

Two norA genes associated with hydrophilic quinolone resistance in Staphylococcus aureus were identified on the two recombinant plasmids pMR8736 and pSA209; the former was derived from a quinolone-resistant strain MR8736, and the latter was derived from a fluoroquinolone-susceptible strain 209P. We compared functions of these two genes, norA8736 and norA209 respectively, by introducing them into E. coli MC1061. Both genes expressed a novel protein of 52 kilodalton (kD) in size in MC1061. However, only norA8736 could confer hydrophilic quinolone resistance to the host cell, which was accompanied by a significant decrease in the uptake of a hydrophilic quinolone, norfloxacin, by the cell. Subcloning and recombinant plasmid analyses localized the hydrophilic quinolone-resistance marker to the 0.5 kilobase (kb)-long HpaI-HinfI DNA fragment of pMR8736. Nucleotide sequencing of this region and the corresponding region of pSA209 revealed that the hydrophilic quinolone resistance conferred by norA8736 was caused by a single nucleotide substitution from A (adenosine) in norA209 to C (cytosine), which corresponded to a single amino acid substitution from Asp to Ala.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173911     DOI: 10.1016/0006-291x(90)91549-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Belen Gutierrez; Laura Hidalgo; Roberto M La Ragione; Manal AbuOun; Marc Galimand; María José Ferrándiz; Lucas Domínguez; Adela G de la Campa; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 3.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

4.  Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli.

Authors:  Robin C Woolley; Govindsamy Vediyappan; Matthew Anderson; Melinda Lackey; Bhagavathi Ramasubramanian; Bai Jiangping; Tatyana Borisova; Jane A Colmer; Abdul N Hamood; Catherine S McVay; Joe A Fralick
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

5.  Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.

Authors:  Govindsamy Vediyappan; Tatyana Borisova; Joe A Fralick
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

6.  Substrate recognition domains as revealed by active hybrids between the D-arabinitol and ribitol transporters from Klebsiella pneumoniae.

Authors:  H Heuel; S Turgut; K Schmid; J W Lengeler
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 7.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

Review 8.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.

Authors:  E Y Ng; M Trucksis; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.

Authors:  T Takenouchi; F Tabata; Y Iwata; H Hanzawa; M Sugawara; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.